IVF · INVO Fertility, Inc. · Executive Compensation
$0.60
+0.00 (+0.10%)
At close · Oct 20
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors, among others, raise substantial doubt about the Company's ability to continue as a going concern for at least one year from the date the accompanying financial statements are issued.”View the 10-Q filed Aug 14, 2026
Market Cap
$1.51M
Shares
2.51M
Volume · Oct 20
68.71K
Avg daily vol (3M)
2.13M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Steven Shum | Chief Executive Officer | $430,863 |
| Terah Krigsvold | Chief Financial Officer | $336,474 |
| Andrea Goren | Chief Business Officer Former Chief Financial Officer | $282,530 |
| Dr. Daniel Teper | Former President | $260,000 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Steven Shum | Chief Executive Officer | $260,000 |
| Andrea Goren | Chief Financial Officer | $215,000 |
| Mr. Michael Campbell | Former Chief Operating Officer Vice President, Business Development | $192,500 |
| Dr. Daniel Teper | Former President | $137,548 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Mr. Michael Campbell | Former Chief Operating Officer Vice President, Business Development | $275,002 |
| Steven Shum | Chief Executive Officer | $232,675 |
| Andrea Goren | Chief Financial Officer | $198,698 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Mr. Michael Campbell | Chief Operating Officer Vice President, Business Development | $1,269,567 |
| Steven Shum | Chief Executive Officer | $402,093 |
| Debra Hoopes | Former Acting Chief Financial Officer | $106,544 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Steven Shum | Chief Executive Officer | $1,347,079 |
| Kathleen Karloff | Former Chief Executive Officer, President (until October 10, 2019) | $526,799 |
| Robert Bowdring | Former Chief Financial Officer ( until August 14, 2019 ) | $365,862 |
| Lori Marzilli-Kahler | Former VP, Global Operations (until August 31, 2020) | $185,000 |
| Mr. Michael Campbell | Chief Operating Officer Vice President, Business Development | $171,354 |
| Debra Hoopes | Former Acting Chief Financial Officer | $69,759 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Lori Marzilli-Kahler | Former VP, Global Operations (until August 31, 2020) | $547,360 |
| Kathleen Karloff | Former Chief Executive Officer, President (until October 10, 2019) | $525,671 |
| Robert Bowdring | Former Chief Financial Officer ( until August 14, 2019 ) | $516,210 |
| Mr. Michael Campbell | Chief Operating Officer Vice President, Business Development | — |
| Debra Hoopes | Chief Financial Officer (since August 14, 2019) | — |
| Steven Shum | Chief Executive Officer (since October 10, 2019) | — |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Andrea Goren | chief business officer | Appointed | 2026-01-06 |
| Andrea Goren | chief financial officer | Resigned | 2026-01-06 |
| Terah Krigsvold | chief financial officer | Appointed | 2026-01-06 |
| Dr. Daniel Teper | President | Resigned | 2025-05-30 |
| Lyn Falconio | director | Appointed | 2024-10-15 |
| Daniel Teper | President | Appointed | 2024-10-15 |
| Daniel Teper | director | Appointed | 2024-10-15 |
| Jeffrey Segal MD | director | Resigned | 2023-04-04 |
Leadership
- Mr. Steven Shum CEO, Board Member
- Steven Shum CEO
- Ms. Terah Krigsvold CFO
- Terah Krigsvold CFO
- Mr. Michael Campbell COO
- Barbara Ryan Board Member
- Daniel Teper Board Member
- Lyn Falconio Board Member
- Matthew Szot Board Member
- Rebecca Messina Board Member